Medical World News® Behind the Science: Experts Discuss Key Research for Pancreatic Cancer Awareness Month
CancerNetwork® spoke with Allyson J. Ocean, MD, Diane M. Simeone, MD, Manuel Hidalgo Medina, MD, PhD, and Andrew E. Hendifar, MD, about their recent research into the treatment of pancreatic cancer.
November is Pancreatic Cancer Awareness month and a good time to reflect on recent advancements in care for patients with these difficult to treat tumors. Since pancreatic tumors rarely produce symptoms in earlier stages, patients typically present with disease that is in advanced stages when it is most difficult to control. Additionally, options for systemic therapies are limited.
In a Behind the Science segment of the Medical World News® broadcast, CancerNetwork® met with Allyson J. Ocean, MD, Diane M. Simeone, MD, Manuel Hidalgo Medina, MD, PhD, and Andrew E. Hendifar, MD, oncologists who specialize in the treatment of pancreatic cancer, to discuss recent research that has the potential to significantly impact care and ongoing trials that clinicians should be aware of.
For a closer look at each of the interviews, see our related articles:
Using Genetic Predispositions to Determine the Likelihood of Being Diagnosed With Pancreatic Cancer
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Pelareorep Combination Shows Manageable Safety in Metastatic Pancreatic Cancer
January 25th 2025Cohort 5 of the ongoing phase 1/2 GOBLET study evaluated the safety of pelareorep in combination with modified FOLFIRINOX with or without atezolizumab in patients with newly diagnosed metastatic pancreatic ductal adenocarcinoma.
